That will not happen with public pharmacare. If you look at what we are paying right now for our health care system, if you include pharmacare, pharmacare will more than pay for itself. Collectively, drug costs will go down. You don't have to go farther than the newspaper. The increased cost of drugs is in the news constantly. If drugs are purchased on a broader scale, then the costs come down, which will help. There are also very expensive usages in our system, for example, patients not having the ongoing care that they need and costing our system more. Consider someone who is diabetic, who is making decisions because of finances and not taking the proper level of insulin or they're not testing as much as they should because they can't afford it; that costs our system more. Although on the surface it looks like we are purchasing a whole bunch of drugs, what we are doing is looking at health care in a more thorough way. If we deal with it at each level, overall we will end up with a system that is more cost-effective. It will not cost the Treasury more money to implement a pharmacare program.
On October 4th, 2016. See this statement in context.